NVO
Price
$45.38
Change
-$1.84 (-3.90%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
210.97B
Earnings call today
TECH
Price
$49.87
Change
-$4.77 (-8.73%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
7.82B
Earnings call today
Interact to see
Advertisement

NVO vs TECH

Header iconNVO vs TECH Comparison
Open Charts NVO vs TECHBanner chart's image
Novo-Nordisk A/S
Price$45.38
Change-$1.84 (-3.90%)
Volume$118.59K
Capitalization210.97B
Bio-Techne
Price$49.87
Change-$4.77 (-8.73%)
Volume$244.68K
Capitalization7.82B
NVO vs TECH Comparison Chart in %
Loading...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVO vs. TECH commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVO is a Hold and TECH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (NVO: $47.22 vs. TECH: $54.64)
Brand notoriety: NVO and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVO: 151% vs. TECH: 123%
Market capitalization -- NVO: $215.92B vs. TECH: $7.82B
NVO [@Biotechnology] is valued at $215.92B. TECH’s [@Biotechnology] market capitalization is $7.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVO’s FA Score shows that 2 FA rating(s) are green whileTECH’s FA Score has 1 green FA rating(s).

  • NVO’s FA Score: 2 green, 3 red.
  • TECH’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than NVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVO’s TA Score shows that 4 TA indicator(s) are bullish while TECH’s TA Score has 4 bullish TA indicator(s).

  • NVO’s TA Score: 4 bullish, 6 bearish.
  • TECH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TECH is a better buy in the short-term than NVO.

Price Growth

NVO (@Biotechnology) experienced а -12.46% price change this week, while TECH (@Biotechnology) price change was -5.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.67%. For the same industry, the average monthly price growth was +14.79%, and the average quarterly price growth was +13.41%.

Reported Earning Dates

NVO is expected to report earnings on Nov 05, 2025.

TECH is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (-0.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVO($211B) has a higher market cap than TECH($7.82B). TECH has higher P/E ratio than NVO: TECH (108.41) vs NVO (12.45). TECH YTD gains are higher at: -23.928 vs. NVO (-44.221). NVO has higher annual earnings (EBITDA): 147B vs. TECH (283M). NVO has more cash in the bank: 41.6B vs. TECH (141M). TECH has less debt than NVO: TECH (423M) vs NVO (119B). NVO has higher revenues than TECH: NVO (303B) vs TECH (1.21B).
NVOTECHNVO / TECH
Capitalization211B7.82B2,699%
EBITDA147B283M51,943%
Gain YTD-44.221-23.928185%
P/E Ratio12.45108.4111%
Revenue303B1.21B25,062%
Total Cash41.6B141M29,504%
Total Debt119B423M28,132%
FUNDAMENTALS RATINGS
NVO vs TECH: Fundamental Ratings
NVO
TECH
OUTLOOK RATING
1..100
5558
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
1480
PRICE GROWTH RATING
1..100
9460
P/E GROWTH RATING
1..100
9846
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (4) in the Biotechnology industry is in the same range as NVO (18) in the Pharmaceuticals Major industry. This means that TECH’s stock grew similarly to NVO’s over the last 12 months.

NVO's Profit vs Risk Rating (83) in the Pharmaceuticals Major industry is in the same range as TECH (100) in the Biotechnology industry. This means that NVO’s stock grew similarly to TECH’s over the last 12 months.

NVO's SMR Rating (14) in the Pharmaceuticals Major industry is significantly better than the same rating for TECH (80) in the Biotechnology industry. This means that NVO’s stock grew significantly faster than TECH’s over the last 12 months.

TECH's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for NVO (94) in the Pharmaceuticals Major industry. This means that TECH’s stock grew somewhat faster than NVO’s over the last 12 months.

TECH's P/E Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for NVO (98) in the Pharmaceuticals Major industry. This means that TECH’s stock grew somewhat faster than NVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVOTECH
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 13 days ago
71%
Declines
ODDS (%)
Bearish Trend 7 days ago
58%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IMCV77.340.11
+0.14%
iShares Morningstar Mid-Cap Value ETF
FCO6.60N/A
N/A
abrdn Global Income Fund
CWS68.59-0.24
-0.35%
AdvisorShares Focused Equity ETF
SDTY44.93-0.19
-0.43%
YieldMax S&P 500 0DTE Cov Cll Stgy ETF
FTEC203.37-1.75
-0.85%
Fidelity MSCI Information Tech ETF

NVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been closely correlated with NONOF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVO jumps, then NONOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-3.26%
NONOF - NVO
70%
Closely correlated
-3.40%
GMAB - NVO
35%
Loosely correlated
+0.55%
TECH - NVO
35%
Loosely correlated
-0.44%
BCAB - NVO
34%
Loosely correlated
+5.58%
AXON - NVO
29%
Poorly correlated
+16.41%
More